Inferensys

Glossary

Corrective and Preventive Action (CAPA)

A systematic process within a Quality Management System (QMS) to investigate, correct, and prevent the recurrence of nonconformities, product failures, and quality issues.
Wide-angle shot of a modern WeWork open floor plan with creative walls covered in AI system architecture diagrams, product team collaborating in standing desk area with industrial lighting.
QUALITY SYSTEM PROCESS

What is Corrective and Preventive Action (CAPA)?

A systematic process within a Quality Management System (QMS) to investigate and correct nonconformities and prevent their recurrence, a critical component of post-market quality for Software as a Medical Device (SaMD).

Corrective and Preventive Action (CAPA) is a structured subsystem of a Quality Management System (QMS) mandated by ISO 13485 and FDA 21 CFR Part 820 to systematically identify, investigate, and resolve product and process nonconformities. The process is bifurcated: corrective action eliminates the root cause of a detected nonconformity to prevent recurrence, while preventive action eliminates the cause of a potential nonconformity to prevent occurrence.

For Software as a Medical Device (SaMD), a CAPA is triggered by sources like Post-Market Surveillance (PMS) data, Medical Device Reporting (MDR) complaints, or internal audit findings. The process requires rigorous root cause analysis, implementation of a fix, and Verification and Validation (V&V) of the action's effectiveness to ensure the correction does not introduce new risk, maintaining the device's safety and Substantial Equivalence (SE).

QUALITY MANAGEMENT SYSTEM

Core Characteristics of an Effective CAPA System

A robust Corrective and Preventive Action (CAPA) system is the engine of continuous improvement within a QMS. It moves beyond simple firefighting to systematically identify root causes and prevent recurrence, ensuring the safety and effectiveness of Software as a Medical Device (SaMD).

01

Risk-Based Prioritization

Not all nonconformities are equal. An effective CAPA system uses a risk matrix to evaluate the severity and probability of harm, ensuring resources are focused on issues with the highest patient safety impact. This aligns directly with ISO 14971 risk management principles.

  • High-risk issues (e.g., a diagnostic false-negative) trigger immediate action.
  • Low-risk issues (e.g., a cosmetic UI glitch) follow a standard workflow.
  • Prioritization prevents resource drain on trivial problems.
02

Rigorous Root Cause Analysis

Correcting a symptom without addressing the source guarantees recurrence. A strong CAPA process mandates formal root cause analysis (RCA) using structured methodologies to drill down to the fundamental process or design failure.

  • 5 Whys: Iterative questioning to peel back layers of symptoms.
  • Fishbone/Ishikawa Diagram: Categorizing causes into groups like methods, materials, and machinery.
  • Fault Tree Analysis (FTA): A top-down, deductive failure analysis for complex systems.
03

Clear Action and Effectiveness Checks

Every CAPA must define a concrete action plan with assigned owners and due dates. Critically, it must also include pre-defined effectiveness checks to verify that the implemented action actually solved the problem and did not introduce new ones.

  • Actions are specific, measurable, and time-bound.
  • Effectiveness is verified with objective data, not anecdotal evidence.
  • A closed CAPA without a verified effectiveness check is a latent risk.
04

Full Lifecycle Traceability

A CAPA is not an isolated event; it's a nexus connecting multiple QMS subsystems. An effective system maintains bidirectional traceability to the source nonconformance, related risk management files, and updated design history documents.

  • Links to the Design History File (DHF) for design changes.
  • Links to the Risk Management File to update hazard analyses.
  • Provides a complete audit trail for regulatory inspectors, proving the loop was closed.
05

Data-Driven Trending and Prevention

The 'P' in CAPA stands for Preventive. A mature system aggregates data from Post-Market Surveillance (PMS) , complaints, and service records to identify negative trends before they become widespread failures. This shifts the organization from a reactive to a proactive quality posture.

  • Statistical process control on complaint data.
  • Analysis of service and nonconformance records for weak signals.
  • Initiating preventive actions based on trend thresholds, not just single events.
06

Integration with Change Management

A corrective action often results in a design or process change. An effective CAPA system is seamlessly integrated with the change control process to ensure the fix is properly documented, verified, and validated before deployment, especially for SaMD where a software update is the deliverable.

  • CAPA output feeds directly into a change order.
  • Ensures changes are reviewed by the same cross-functional team.
  • Prevents unauthorized 'quick fixes' that bypass design controls.
CORRECTIVE AND PREVENTIVE ACTION

Frequently Asked Questions

Clear answers to the most common regulatory and operational questions about the CAPA process within a medical device Quality Management System.

A Corrective and Preventive Action (CAPA) is a systematic, documented process within a Quality Management System (QMS) used to investigate, identify, and resolve nonconformities related to a medical device or its manufacturing process. The 'corrective' component focuses on eliminating the root cause of a detected nonconformity to prevent its recurrence, while the 'preventive' component proactively identifies and eliminates the causes of potential nonconformities to prevent their occurrence entirely. For Software as a Medical Device (SaMD), this includes addressing software bugs, algorithmic performance drift, cybersecurity vulnerabilities, and usability errors identified during Post-Market Surveillance (PMS). It is a mandatory subsystem for compliance with ISO 13485 and FDA's 21 CFR Part 820, ensuring continuous improvement and patient safety.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.